Insulet Corporation and DexCom Announce Development Agreement

Insulet's OmniPod(R) Personal Diabetes Manager to Integrate DexCom Continuous Glucose Monitoring Technology BEDFORD, Mass. and SAN DIEGO, Jan. 7 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD ), the leader in wearable insulin pump technology with its OmniPod(R) ...

Automated 'Artificial Pancreas' Controls Blood Glucose Levels in Diabetes Patients for First Time

...automated insulin delivery system comprising the OmniPod(R) System and the dexcom STS7(R) continuous glucose monitor, linked and controlled through UCSB's ar... it--is manufactured and sold by Insulet Corporation (Nasdaq: PODD ). The dexcom STS7 continuous glucose monitor is a product of DexCom, Inc. (1) abstr...

Researchers Successfully Create Computer-Simulated Model for Evaluating Artificial Pancreas

...uous glucose monitor, in this case either the FreeStyle Navigator(R) or the dexcom STS7(R). The system also includes an algorithm that automates the interacti...DD ). The FreeStyle Navigator is a product of Abbott Diabetes Care, and the dexcom STS7 is a product of DexCom, Inc. Media Contacts: Mark Sahl,...

DexCom in Medical Products

DexCom™ STS™ Continuous Glucose Monitoring System

Description:... The dexcom STS Continuous Glucose Monitoring System is a pati...wirelessly transmits blood glucose readings to the dexcom STS Receiver. The dexcom STS Sensor includes a wirelike sensor which is ins...
Company:DexCom Inc.

DexCom in Biological Technology

Marinus Pharmaceuticals Raises $20 Million in Series B Financing

...mmunications & mobility, enterprise and clean tech industries. Among its successes are Acme Packet, Amicus Therapeutics, Cerexa Inc., CommerceOne, dexcom Inc., DoubleClick, IntraLinks, Match.com, SuccessFactors and WebLoyalty. Other Canaan investments include Active Networks, AdvancedBioHealing, BharatM...

Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer

.... Among recent successes are Cerexa Inc., one of the largest biotech acquisitions of 2007; Advanced BioHealing, a leader in regenerative medicine; and dexcom Inc., the largest diagnostic IPO of 2005. Other Canaan healthcare investments include Amicus Therapeutics, Chimerix, Inc., ReVision Optics, Inc., and ...

Insulet Reports First Quarter 2008 Results

...leverage the OmniPod System for ongoing innovation. The agreement with dexcom to integrate its continuous glucose monitoring technology into the wire...evelopment efforts including those related to the Company's agreements with dexcom and Abbott, sales and marketing efforts, product demand and financial perfo...